BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9539 related articles for article (PubMed ID: 1377562)

  • 1. Combined morphological approaches in the study of network formation in tumor angiogenesis.
    Konerding MA; van Ackern C; Steinberg F; Streffer C
    EXS; 1992; 61():40-58. PubMed ID: 1377562
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?
    Bissell MJ
    Am J Pathol; 1999 Sep; 155(3):675-9. PubMed ID: 10487823
    [No Abstract]   [Full Text] [Related]  

  • 3. New paradigm for vessel intravasation by tumor cells.
    Weidner N
    Am J Pathol; 2002 Jun; 160(6):1937-9. PubMed ID: 12057896
    [No Abstract]   [Full Text] [Related]  

  • 4. On chlorpromazine binding in vivo.
    Blois MS
    J Invest Dermatol; 1965 Dec; 45(6):475-81. PubMed ID: 5847002
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoperoxidase staining of fine needle aspiration specimens previously stained by the Papanicolaou technique.
    Travis WD; Wold LE
    Acta Cytol; 1987; 31(4):517-20. PubMed ID: 2440215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of quercetin isolated from rose hip (Rosa canina L.) against melanogenesis by mouse melanoma cells.
    Fujii T; Saito M
    Biosci Biotechnol Biochem; 2009 Sep; 73(9):1989-93. PubMed ID: 19734679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3-D imaging of skin cancers and survival].
    Piérard GE
    Rev Med Liege; 2009 Apr; 64(4):187-91. PubMed ID: 19514537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells.
    Reiland J; Kempf D; Roy M; Denkins Y; Marchetti D
    Neoplasia; 2006 Jul; 8(7):596-606. PubMed ID: 16867222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet carcinogenesis in nonmelanoma skin cancer part II: review and update on epidemiologic correlations.
    Almahroos M; Kurban AK
    Skinmed; 2004; 3(3):132-9. PubMed ID: 15133392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peritumoral administered IL-2-induced tumor regression in melanoma. Pilot study].
    Gutwald J; Groth W; Mahrle G
    Hautarzt; 1994 Aug; 45(8):536-40. PubMed ID: 7960753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies.
    Bernengo MG; Lisa F; Puiatti P; Meregalli M; Berruto G; Zina G
    Thymus; 1983 Apr; 5(3-4):223-33. PubMed ID: 6224319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of some tumours of human origin. II. Chromosome and late replication analysis of parental tumours, metastasis and ascites of the HR 18 rat tumour.
    Popescu NC; Cioloca L; Olăianos E
    Eur J Cancer (1965); 1970 Jun; 6(3):181-5. PubMed ID: 5477975
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of xeroderma pigmentosum (XP); variability and stability within and between the complementation groups C, D, E, I and variants.
    Jung EG; Bohnert E; Fischer E
    Photodermatol; 1986 Jun; 3(3):125-32. PubMed ID: 3748852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveal melanoma and similar lesions: the role of magnetic resonance imaging and computed tomography.
    Peyman GA; Mafee MF
    Radiol Clin North Am; 1987 May; 25(3):471-86. PubMed ID: 3554332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of blocked and non-blocked ricin-antibody immunotoxins against human gastric carcinoma and colorectal adenocarcinoma cell lines.
    Cattel L; Delprino L; Brusa P; Dosio F; Comoglio PM; Prat M
    Cancer Immunol Immunother; 1988; 27(3):233-40. PubMed ID: 3263208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells.
    de Vries JE; Keizer GD; te Velde AA; Voordouw A; Ruiter D; Rümke P; Spits H; Figdor CG
    Int J Cancer; 1986 Oct; 38(4):465-73. PubMed ID: 2428758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cepharanthine on cell-type conversion in B16 mouse melanoma cells.
    Takeuchi T; Sato S
    J Dermatol; 1985 Apr; 12(2):138-42. PubMed ID: 2411775
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual metastases from a malignant melanoma. A case report.
    Blumenfeld D; Berman ML; Kerner H; DiSaia PJ
    J Reprod Med; 1991 Sep; 36(9):688-90. PubMed ID: 1774737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolysis with trypsin of mammalian tyrosinase isoforms from B16 mouse melanoma.
    Valverde P; García-Borrón JC; Solano F; Lozano JA
    Arch Biochem Biophys; 1992 Sep; 297(2):221-7. PubMed ID: 1497341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 477.